Britain would face 100% tariff on pharmaceuticals under latest Trump plan, sources say

ReutersSep 26, 2025 6:21 PM

View all comments（0）



WASHINGTON, Sept 26 (Reuters) - Britain would face 100% tariffs on pharmaceuticals under President Donald Trump's latest plan, sources told Reuters on Friday.

Trump said a new 100% tariff would apply to firms unless they build a manufacturing presence in the United States.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Japan and South Korea Stocks Open Lower, Samsung Strike Storm and Higher-Than-Expected Inflation Disrupt Markets

TradingKey - On May 13, the Nikkei 225 Index opened 0.5% lower, while South Korea’s KOSPI Index opened down 1.7% before losses further widened to 3%.

Today’s Market Recap: US Inflation Hits 3-Year Peak as Market Braces for Trump’s China Visit and Fed Leadership Shift

April inflation hit a three-year peak of 3.8%, pressuring the Nasdaq and tech stocks. Markets are further braced by Kevin Warsh’s Fed Chair confirmation, the maintenance of Trump’s 10% global tariffs, and a high-profile U.S. business delegation preparing for a strategic state visit to China.

BigBear.ai Stock Down 26% YTD – Should You Invest in BBAI Stock in 2026? Can the Ask Sage Deal Lead to a Rebound?

TradingKey - BigBear.ai (BBAI) provided a modest first-quarter update on May 5, and BBAI shares have declined about 26% year to date. The company finalized the acquisition of Ask Sage in January, marking its shift away from a services-heavy government contractor to a platform-centric AI company. The

Cerebras Systems IPO 2026: Date, Price, Valuation, and Whether CBRS Is Worth Buying

TradingKey - Cerebras Systems (CBRS) IPO prices May 13–14 at $125–$135/share. $26–$27B valuation, 20x oversubscribed, $510M revenue, 47% net margin, OpenAI 750MW deal. Everything you need to know.

AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

TradingKey - On May 5 (ET), Advanced Micro Devices (AMD) released its first-quarter fiscal 2026 financial results after the market close. The company reported revenue of $10.253 billion, up 38% year-over-year, exceeding market expectations of $9.89 billion. Non-GAAP earnings per share (EPS) were $1.

Featured Tools